HER2 Support Group Forums - View Single Post - Breast Cancer Patients Benefit From Continued Use of Herceptin After Progression

tousled1 · 12-16-2007, 04:50 AM

Data presented at the 30th Annual San Antonio Breast Cancer Symposium confirm that Herceptin is the standard of care for women with HER2-positive breast cancer across all stages of the disease

Full article:
http://www.presseportal.de/pm/24678/...harmaceuticals

12-16-2007, 04:50 AM	#1
tousled1 Senior Member Join Date: Feb 2006 Location: Acworth, GA Posts: 2,104	Breast Cancer Patients Benefit From Continued Use of Herceptin After Progression Data presented at the 30th Annual San Antonio Breast Cancer Symposium confirm that Herceptin is the standard of care for women with HER2-positive breast cancer across all stages of the disease Full article: http://www.presseportal.de/pm/24678/...harmaceuticals __________________ Kate Stage IIIC Diagnosed Oct 25, 2005 (age 58) ER/PR-, HER2+++, grade 3, Ploidy/DNA index: Aneuploid/1.61, S-phase: 24.2% Neoadjunct chemo: 4 A/C; 4 Taxatore Bilateral mastectomy June 8, 2006 14 of 26 nodes positive Herceptin June 22, 2006 - April 20, 2007 Radiation (X35) July 24-September 11, 2006 BRCA1/BRCA2 negative Stage IV lung mets July 13, 2007 - TCH Single brain met - August 6, 2007 -CyberKnife Oct 2007 - clear brain MRI and lung mets shrinking. March 2008 lung met progression, brain still clear - begin Tykerb/Xeloda/Ixempra